Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Other financing activities (2016 - 2025)

Anaptysbio's Other financing activities history spans 7 years, with the latest figure at $1.5 million for Q4 2025.

  • For Q4 2025, Other financing activities rose 273.01% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $1.9 million, up 287.6%, while the annual FY2025 figure was $1.5 million, 194.92% up from the prior year.
  • Other financing activities reached $1.5 million in Q4 2025 per ANAB's latest filing, up from $389000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.5 million in Q4 2025 to a low of -$290000.0 in Q4 2022.
  • Average Other financing activities over 4 years is $215888.9, with a median of $43000.0 recorded in 2023.
  • The largest YoY upside for Other financing activities was 2050.0% in 2023 against a maximum downside of 114.93% in 2023.
  • A 4-year view of Other financing activities shows it stood at -$290000.0 in 2022, then surged by 85.17% to -$43000.0 in 2023, then skyrocketed by 1004.65% to $389000.0 in 2024, then soared by 273.01% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Other financing activities are $1.5 million (Q4 2025), $389000.0 (Q4 2024), and $67000.0 (Q3 2024).